Clinical Research on 40Hz Light Therapy for Dementia
Dr. Maibritt Horning leads OptoCeutics' clinical research on dementia and Alzheimer's disease. Join her as she walks through our studies, shares what we're finding, and explains how our work fits into the growing body of 40Hz gamma stimulation research.

Clinical Researcher at OptoCeutics
Maibritt leads OptoCeutics' clinical research program on dementia and Alzheimer's disease. She holds a background in Cognitive Science and Neuroscience, recently completed an industrial PhD in collaboration between the University of Copenhagen and OptoCeutics, and currently contributes to the ALZLIGHT clinical study at Region Zealand University Hospital.
- OptoCeutics' clinical studies on dementia and Alzheimer's — what we're researching and why
- Key findings from our research so far
- How OptoCeutics' work fits into the broader 40Hz gamma stimulation research landscape
- Live Q&A — bring your questions for the researcher
Register below and we'll send you the link to join live. Can't make it? Sign up anyway — we'll send you the recording.
This is a research-focused webinar, not a sales presentation.
All are welcome — caregivers, family members, healthcare providers, and anyone curious about the science.



New: Independent Memory Care Study